The Effects of Cardiopulmonary Bypass on Remifentanil Kinetics in Children Undergoing Atrial Septal Defect Repair
- 1 October 1999
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 89 (4) , 904
- https://doi.org/10.1213/00000539-199910000-00016
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Do Shorter-acting Neuromuscular Blocking Drugs or Opioids Associate with Reduced Intensive Care Unit or Hospital Lengths of Stay after Coronary Artery Bypass Grafting?Anesthesiology, 1998
- A1064 REMIFENTANIL PHARMACOKINETICS IN NEONATESAnesthesiology, 1997
- A Randomized Multicenter Study of Remifentanil Compared with Alfentanil, Isoflurane, or Propofol in Anesthetized Pediatric Patients Undergoing Elective Strabismus SurgeryAnesthesia & Analgesia, 1997
- A Randomized Multicenter Study of Remifentanil Compared with Alfentanil, Isoflurane, or Propofol in Anesthetized Pediatric Patients Undergoing Elective Strabismus SurgeryAnesthesia & Analgesia, 1997
- Remifentanil and Pulmonary Extraction During and After Cardiac AnesthesiaAnesthesia & Analgesia, 1997
- Remifentanil and Pulmonary Extraction During and After Cardiac AnesthesiaAnesthesia & Analgesia, 1997
- Clinical Pharmacokinetics of Alfentanil, Fentanyl and SufentanilClinical Pharmacokinetics, 1996
- Alfentanil Pharmacokinetics in Cardiac Surgical PatientsAnesthesia & Analgesia, 1994
- Pharmacokinetics of Remifentanil (GI87084B) and Its Major Metabolite (GI90291) in Patients Undergoing Elective Inpatient SurgeryAnesthesiology, 1993
- Effect of Cardiopulmonary Bypass on the Pharmacokinetics of DrugsClinical Pharmacokinetics, 1982